The Horae Gene Therapy Center of the University of Massachusetts Medical School invites applications for postdoctoral researcher positions. Our research focuses on using AAV vectors for gene therapy of neurological and other disorders. Applicants should have a PhD in the biomedical sciences or an MD with post-graduate scientific training, and three to five years of research experience in the fields of neuroscience, molecular biology, immunology, animal modeling, bioengineering, and gene therapy.
Applicants with a strong background and track record in molecular cloning, creation of viral packaging cell lines, viral vector production and downstream processing, high-throughput DNA and RNA Seq, single-cell sequencing, bioinformatics analyses of exome, transcriptome, and small RNA NGS data, viral vectorology, in vivo gene transfer studies, assessing biological/therapeutic outcomes, vector and transgene immunotoxicity of gene replacement, silencing, editing and addition therapies, conventional and confocal microscopic analyses of tissue sections and image processing are highly preferred.
Applicants must also have the ability to work independently, coordinate multiple projects and activities concurrently. Strong writing, verbal, and interpersonal skills are required. Candidates should be highly organized, hard-working and motivated to respond to the changes within the rapidly evolving field of gene therapy. We offer excellent benefits and a competitive salary depending on experiencing and tracking records. For further information, please send cover letter, current CV and the names
and contact information of three references to:
Dr. Guangping Gao, PhD
Professor and Director, Horae Gene Therapy Center
University of Massachusetts Medical School
368 Plantation Street, AS6-2049
Worcester, MA 01605
Office: 508-856-3563; 508-856-3394
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. As a research institution, UMMS attracts nearly $300 million annually in funding from government agencies, private groups, and
Faculty members are nationally recognized authorities in areas ranging from cancer to diabetes to genetics and are regularly honored for their work. As an equal opportunity and affirmative action employer, UMMS recognizes the power of a diverse community
and encourages applications from individuals with varied experiences, perspectives and backgrounds